Hangzhou Diagens Biotechnology Co (HKSE:02526) Interest Coverage: N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02526 Hangzhou Diagens Biotechnology Co Ltd HKSE:02526
8 GF Score
Price HK$370.00
! 1 Warning Sign
View Full Analysis

What is Hangzhou Diagens Biotechnology Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Hangzhou Diagens Biotechnology Co's Operating Income for the three months ended in Jun. 2026 was HK$0.00 Mil. Hangzhou Diagens Biotechnology Co's Interest Expense for the three months ended in Jun. 2026 was HK$0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Hangzhou Diagens Biotechnology Co's Interest Coverage or its related term are showing as below:


HKSE:02526's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 16.545
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hangzhou Diagens Biotechnology Co  (HKSE:02526) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Hangzhou Diagens Biotechnology Co Interest Coverage Related Terms

Hangzhou Diagens Biotechnology Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Hangzhou Diagens Biotechnology Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Hangzhou Diagens Biotechnology Co Interest Coverage Chart

Hangzhou Diagens Biotechnology Co Annual Data
Trend Dec23 Dec24 Dec25
Interest Coverage
0.00 0.00 0.00

Hangzhou Diagens Biotechnology Co Quarterly Data
Dec23 Dec24 Sep25 Dec25 Jun26
Interest Coverage N/A 2.66 0.00 0.00 N/A

HKSE:02526 vs ABT, SYK, MDT: Interest Coverage Comparison

For the Medical Devices subindustry, Hangzhou Diagens Biotechnology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Diagens Biotechnology Co Interest Coverage vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou Diagens Biotechnology Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Hangzhou Diagens Biotechnology Co's Interest Coverage falls into.


HKSE:02526
8GF Score
Hangzhou Diagens Biotechnology Co Ltd HKSE:02526
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Diagens Biotechnology Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hangzhou Diagens Biotechnology Co's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Hangzhou Diagens Biotechnology Co's Interest Expense was HK$-0.64 Mil. Its Operating Income was HK$-66.69 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$4.91 Mil.

Hangzhou Diagens Biotechnology Co did not have earnings to cover the interest expense.

Hangzhou Diagens Biotechnology Co's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Here, for the three months ended in Jun. 2026, Hangzhou Diagens Biotechnology Co's Interest Expense was HK$0.00 Mil. Its Operating Income was HK$0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$4.97 Mil.

GuruFocus does not calculate Hangzhou Diagens Biotechnology Co's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Hangzhou Diagens Biotechnology Co Business Description

Address No. 609 Hongfeng Road, Room 101, Building 1, Donghu Sub-district, Linping District, Zhejiang, Hangzhou, CHN
Hangzhou Diagens Biotechnology Co Ltd and its subsidiaries are involved in the development and commercialisation of medical imaging artificial intelligence technologies and medical imaging equipment. It has self-developed a diversified portfolio, including six medical imaging software products, three commercialized medical devices, four key reagents and consumables and two technology licensing offerings. Its Core Product, AI AutoVision, is an auxiliary diagnostic software designed to undertake intelligent analysis on chromosome karyotyping. The majority of the company's revenue is derived from Technology Licensing, mainly in the Chinese mainland.
8GF Score

Get the complete analysis for HKSE:02526

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$370.00
Price